Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 178

1.

Structure-dynamic and functional relationships in a Li+-transporting sodium‑calcium exchanger mutant.

Giladi M, Lee SY, Refaeli B, Hiller R, Chung KY, Khananshvili D.

Biochim Biophys Acta Bioenerg. 2019 Mar 1;1860(3):189-200. doi: 10.1016/j.bbabio.2018.11.015. Epub 2018 Nov 8.

PMID:
30414928
2.

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields).

Shteingauz A, Porat Y, Voloshin T, Schneiderman RS, Munster M, Zeevi E, Kaynan N, Gotlib K, Giladi M, Kirson ED, Weinberg U, Kinzel A, Palti Y.

Cell Death Dis. 2018 Oct 19;9(11):1074. doi: 10.1038/s41419-018-1085-9.

3.

Reduced Activity of Geranylgeranyl Diphosphate Synthase Mutant Is Involved in Bisphosphonate-Induced Atypical Fractures.

Lisnyansky M, Kapelushnik N, Ben-Bassat A, Marom M, Loewenstein A, Khananshvili D, Giladi M, Haitin Y.

Mol Pharmacol. 2018 Dec;94(6):1391-1400. doi: 10.1124/mol.118.113670. Epub 2018 Oct 1.

PMID:
30275041
4.

Key residues controlling bidirectional ion movements in Na+/Ca2+ exchanger.

van Dijk L, Giladi M, Refaeli B, Hiller R, Cheng MH, Bahar I, Khananshvili D.

Cell Calcium. 2018 Dec;76:10-22. doi: 10.1016/j.ceca.2018.09.004. Epub 2018 Sep 15.

PMID:
30248574
5.

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.

Maertens J, Selleslag D, Heinz WJ, Saulay M, Rahav G, Giladi M, Aoun M, Kovanda L, Kaufhold A, Engelhardt M, Cornely OA, Herbrecht R, Ullmann AJ.

Mycoses. 2018 Nov;61(11):868-876. doi: 10.1111/myc.12831. Epub 2018 Aug 13.

PMID:
30035825
6.

A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.

Wenger C, Miranda PC, Salvador R, Thielscher A, Bomzon Z, Giladi M, Mrugala MM, Korshoej AR.

IEEE Rev Biomed Eng. 2018;11:195-207. doi: 10.1109/RBME.2017.2765282. Epub 2018 Feb 13. Review.

PMID:
29993870
7.

The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.

Harcourt JL, Rudoler N, Tamin A, Leshem E, Rasis M, Giladi M, Haynes LM.

Zoonoses Public Health. 2018 May 31. doi: 10.1111/zph.12482. [Epub ahead of print]

PMID:
29855166
8.

Inherent flexibility of CLIC6 revealed by crystallographic and solution studies.

Ferofontov A, Strulovich R, Marom M, Giladi M, Haitin Y.

Sci Rep. 2018 May 2;8(1):6882. doi: 10.1038/s41598-018-25231-z.

9.

Isavuconazole for treatment of rare invasive fungal diseases.

Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G.

Mycoses. 2018 Aug;61(8):518-533. doi: 10.1111/myc.12778.

PMID:
29611246
10.

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.

Marty FM, Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Oren I, Schmitt-Hoffmann AH, Giladi M, Rahav G, Perfect JR.

Mycoses. 2018 Jul;61(7):485-497. doi: 10.1111/myc.12777. Epub 2018 Apr 26.

PMID:
29611227
11.

Cat-scratch disease: ocular manifestations and treatment outcome.

Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, Amer R, David R, Ben-Arie-Weintrob Y, Bakshi E, Almog Y, Sartani G, Vishnevskia-Dai V, Kramer M, Bar A, Kehat R, Ephros M, Giladi M.

Acta Ophthalmol. 2018 Jun;96(4):e524-e532. doi: 10.1111/aos.13684. Epub 2018 Mar 5.

PMID:
29504674
12.

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.

Giladi M, Munster M, Schneiderman RS, Voloshin T, Porat Y, Blat R, Zielinska-Chomej K, Hååg P, Bomzon Z, Kirson ED, Weinberg U, Viktorsson K, Lewensohn R, Palti Y.

Radiat Oncol. 2017 Dec 29;12(1):206. doi: 10.1186/s13014-017-0941-6.

13.

Perioperative complications of emergent and elective procedures in psychiatric patients.

Hassidim A, Bratman Morag S, Giladi M, Dagan Y, Tzadok R, Reissman P, Dagan A.

J Surg Res. 2017 Dec;220:293-299. doi: 10.1016/j.jss.2017.07.018. Epub 2017 Aug 12.

PMID:
29180194
14.

The Crystal Structure and Conformations of an Unbranched Mixed Tri-Ubiquitin Chain Containing K48 and K63 Linkages.

Padala P, Soudah N, Giladi M, Haitin Y, Isupov MN, Wiener R.

J Mol Biol. 2017 Dec 8;429(24):3801-3813. doi: 10.1016/j.jmb.2017.10.027. Epub 2017 Oct 27.

PMID:
29111344
15.

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli.

Edri I, Goldenberg M, Lisnyansky M, Strulovich R, Newman H, Loewenstein A, Khananshvili D, Giladi M, Haitin Y.

J Vis Exp. 2017 Aug 3;(126). doi: 10.3791/56430.

PMID:
28809830
16.

Bartonella quintana, an Unrecognized Cause of Infective Endocarditis in Children in Ethiopia.

Tasher D, Raucher-Sternfeld A, Tamir A, Giladi M, Somekh E.

Emerg Infect Dis. 2017 Aug;23(8). doi: 10.3201/eid2308.161037.

17.

Dynamic distinctions in the Na+/Ca2+ exchanger adopting the inward- and outward-facing conformational states.

Giladi M, van Dijk L, Refaeli B, Almagor L, Hiller R, Man P, Forest E, Khananshvili D.

J Biol Chem. 2017 Jul 21;292(29):12311-12323. doi: 10.1074/jbc.M117.787168. Epub 2017 Jun 1.

18.

Giant pyogenic granuloma of the finger in an HIV-positive patient.

Kohavi LK, Rogers T, Giladi M, Dekel M, Gat A, Bentwich Z, Katz O, Sprecher E, Goldberg I.

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e512-e513. doi: 10.1111/jdv.14362. Epub 2017 Aug 4. No abstract available.

PMID:
28556978
19.

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).

Porat Y, Giladi M, Schneiderman RS, Blat R, Shteingauz A, Zeevi E, Munster M, Voloshin T, Kaynan N, Tal O, Kirson ED, Weinberg U, Palti Y.

J Vis Exp. 2017 May 4;(123). doi: 10.3791/55820.

20.

Strabismus and mental disorders among Israeli adolescents.

Merdler I, Giladi M, Sorkin N, Shapira S, Galili E, Margulis A, Korach T, Hassidim A.

J AAPOS. 2017 Jun;21(3):185-189. doi: 10.1016/j.jaapos.2017.04.001. Epub 2017 Apr 19.

PMID:
28433442

Supplemental Content

Loading ...
Support Center